In conclusion, NOL1 rs3764909 and NSUN4 rs10252 variants were enhanced by pediatric ALL risk and were suggested to be potential biomarkers for pediatric ALL. This evidence concerns the gene NOP2 and acute lymphoblastic leukemia.